These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6133662)

  • 1. Diseases of the TSH receptor.
    Davies TF
    Clin Endocrinol Metab; 1983 Mar; 12(1):79-100. PubMed ID: 6133662
    [No Abstract]   [Full Text] [Related]  

  • 2. [Can growth-stimulating immunoglobulins (TGI) explain sporadic euthyroid goiters?].
    Doniach D
    Ann Endocrinol (Paris); 1982 Dec; 43(6):534-47. PubMed ID: 6134494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TSH receptor antibodies in clinical practice.
    Orgiazzi J
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):339-55, vii. PubMed ID: 10874533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioreceptor assay study of TSH receptor antibody in thyroid diseases.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1985 Jan; 84(1):18-26. PubMed ID: 2860200
    [No Abstract]   [Full Text] [Related]  

  • 5. The implications of "thyroid-growth-immunoglobulins" (TGI) for the understanding of sporadic nontoxic nodular goitre.
    Doniach D; Chiovato L; Hanafusa T; Bottazzo GF
    Springer Semin Immunopathol; 1982; 5(4):433-46. PubMed ID: 6131546
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of anti-TSH receptor antibodies in thyroid diseases].
    Arikawa K
    Nihon Naibunpi Gakkai Zasshi; 1983 Feb; 59(2):131-47. PubMed ID: 6303869
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease.
    Kohn LD; Valente WA; Laccetti P; Cohen JL; Aloj SM; Grollman EF
    Life Sci; 1983 Jan 3-10; 32(1-2):15-30. PubMed ID: 6298540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):133-40. PubMed ID: 16232366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LATS and other antibodies against the TSH receptor].
    Rodríguez Zapata MM
    Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
    [No Abstract]   [Full Text] [Related]  

  • 12. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune thyroid disease.
    Bottazzo GF; Doniach D
    Annu Rev Med; 1986; 37():353-9. PubMed ID: 2871804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 15. Two types of thyroid function-blocking antibodies in autoimmune atrophic thyroiditis and transient neonatal hypothyroidism due to maternal IgG.
    Takasu N; Naka M; Mori T; Yamada T
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):345-55. PubMed ID: 6096043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease.
    Lacetti P; Tombaccini D; Aloj S; Grollman EF; Kohn LD
    Adv Exp Med Biol; 1984; 174():355-67. PubMed ID: 6331133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and clinical correlates of a novel thyroid-stimulating autoantibody.
    Zakarija M; De Forteza R; McKenzie JM; Ghandur-Mnaymneh L
    Autoimmunity; 1994; 19(1):31-7. PubMed ID: 7749040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.
    Kosugi S; Ban T; Akamizu T; Valente W; Kohn LD
    J Clin Endocrinol Metab; 1993 Jul; 77(1):19-24. PubMed ID: 8100829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of thyroid-stimulating antibody (TSAb) in the management and prognostic evaluation of Graves disease.
    Leövey A; Kálmán K; Bakó G; Szabó T
    Acta Med Hung; 1985; 42(1-2):3-11. PubMed ID: 2863805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
    Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
    J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.